9th MASH Drug Development Summit 2025
17 17 people viewed this event.
Driven by a surging pipeline, the MASH therapeutic landscape is radically transforming as more drugs reach clinical trials. While Madrigal’s Rezdiffra marked a groundbreaking first approval, it also highlighted the vast scope for further, more comprehensive, patient-centered solutions. This is a pivotal moment to unlock unparalleled potential in conquering this widespread disease.
Time: 8:00 AM – 5:00 PM
Venue Details: Hyatt Regency Boston / Cambridge, 575 Memorial Drive, Cambridge, Massachusetts, 02139, United States
Prices: USD 2599.00 – USD 5097.00
Topics: mash, drugdevelopment, noninvasivebio-markers, combinationandsequential, mashtreatment
Event Organizer: Hanson Wade